Treatment of Arrhythmias During Pregnancy
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved..
Cardiac disease is the most common cause of maternal mortality in developed nations. Cardiac arrhythmias are frequent among patients with structural heart disease and may require immediate treatment to prevent hemodynamic instability leading to acute maternal and fetal decompensation. Antiarrhythmic therapy during pregnancy should follow the same principles recommended for nonpregnant individuals. Although multidisciplinary management is recommended, obstetricians, and maternal-fetal medicine specialists may sometimes need to emergently recognize and treat rhythm anomalies before support services become available.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Clinical obstetrics and gynecology - 66(2023), 1 vom: 01. März, Seite 163-175 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pacheco, Luis D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.01.2023 Date Revised 22.04.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/GRF.0000000000000747 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346783089 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346783089 | ||
| 003 | DE-627 | ||
| 005 | 20231226032253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/GRF.0000000000000747 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM346783089 | ||
| 035 | |a (NLM)36162092 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pacheco, Luis D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of Arrhythmias During Pregnancy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2023 | ||
| 500 | |a Date Revised 22.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a Cardiac disease is the most common cause of maternal mortality in developed nations. Cardiac arrhythmias are frequent among patients with structural heart disease and may require immediate treatment to prevent hemodynamic instability leading to acute maternal and fetal decompensation. Antiarrhythmic therapy during pregnancy should follow the same principles recommended for nonpregnant individuals. Although multidisciplinary management is recommended, obstetricians, and maternal-fetal medicine specialists may sometimes need to emergently recognize and treat rhythm anomalies before support services become available | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Arrhythmia Agents |2 NLM | |
| 700 | 1 | |a Eyada, Mostafa |e verfasserin |4 aut | |
| 700 | 1 | |a Saade, George R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical obstetrics and gynecology |d 1958 |g 66(2023), 1 vom: 01. März, Seite 163-175 |w (DE-627)NLM000175544 |x 1532-5520 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2023 |g number:1 |g day:01 |g month:03 |g pages:163-175 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/GRF.0000000000000747 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2023 |e 1 |b 01 |c 03 |h 163-175 | ||